San Francisco 17 April 2019 Neurovascular Devices Market Size, Share & Trends Analysis Report By Therapeutic
Application (Stroke, Cerebral Artery Stenosis, Cerebral Aneurysm), By Device
Type, By Region, And Segment Forecasts, 2019 - 2026
The global neurovascular devices market size is estimated to reach USD 3.1 billion by 2026, according to a new report by Grand View Research, Inc. The market is estimated to expand at a CAGR of 5.3% over the forecast years. Preference for minimally invasive surgeries in the treatments of brain aneurysm and stroke is expected to be the key factor augmenting the market growth.
Technological advancements have increased
life expectancy, leading to a consequent increase in geriatric population.
According to a report published by United Nations, geriatric population (aged
60 years and above) is projected to increase by 56% from 901 million in 2015 to
1.4 billion by 2030. Therefore, rise in aging population across the globe is
anticipated to impel the demand for neurovascular devices.
The market holds immense growth potential,
and hence, manufacturers are focus on R&D to develop advanced products.
Technological developments in the field of neurovascular therapy, such as
development of GORE TIGRIS by W L Gore and SpiderFX distal filter embolic
protection device by Medtronic, are expected to serve as a high impact
rendering driver.
North America was the largest regional
market in 2018 in terms of revenue and is expected to continue its dominance
through the forecast period. Asia Pacific is anticipated to be the
fastest-growing region with a CAGR of 6.0% in the estimated time. Wide adoption
of innovative treatment approaches and growing per capita income, especially in
the developing economies, are boosting the market growth in this region.
Access Research Report of Neurovascular
Devices Market @ https://www.grandviewresearch.com/industry-analysis/neurovascular-devices-market
Further key findings from the study suggest:
· Cerebral embolization and aneurysm coiling
devices accounted for the majority of the global market share in 2018
· In 2018, stroke was estimated to be the
most prevalent therapeutic application for neurovascular devices
· Cerebral aneurysm is projected to be the
fastest-growing therapeutic application with a CAGR of 6.0% during the forecast
period
· Japan is a major revenue-generator in Asia
Pacific region as nearly one in three Japanese people are older than 60 years
· Key companies in this market include Abbott
Laboratories; W. L. Gore & Associates, Inc.; Medtronic, Inc.; Stryker
Corporation; and Merit Medical Systems, Inc.
Browse more reports of this category by Grand View
Research at: https://www.grandviewresearch.com/industry/medical-devices
Grand View Research has
segmented the global neurovascular devices market on the basis of device type,
therapeutic applications, and region:
Neurovascular Device Type (Revenue,
USD Million, 2014 - 2026)
·
Cerebral Embolization and Aneurysm Coiling
·
Cerebral Angioplasty and Stenting Systems
·
Neurothrombectomy
·
Support
Neurovascular Devices Therapeutic Application
Outlook (Revenue, USD Million, 2014 - 2026)
·
Stroke
·
Cerebral Artery Stenosis
·
Cerebral Aneurysm
·
Others
Neurovascular Devices Regional Outlook
(Revenue, USD Million, 2014 - 2026)
·
North America
·
Europe
·
Asia Pacific
·
Latin America
·
Middle East & Africa
Access Press Release of
Neurovascular
Devices Market@ https://www.grandviewresearch.com/press-release/global-neurovascular-devices-market-size-report
About
Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco.
The company provides syndicated research reports, customized research
reports, and consulting services. To help clients make informed business decisions,
we offer market intelligence studies ensuring relevant and fact-based research
across a range of industries, from technology to chemicals, materials and
healthcare.
No comments:
Post a Comment